Found: 4
Select item for more details and to access through your institution.
Docetaxel versus abiraterone for metastatic hormone‐sensitive prostate cancer with focus on efficacy of sequential therapy.
- Published in:
- Prostate, 2023, v. 83, n. 6, p. 563, doi. 10.1002/pros.24488
- By:
- Publication type:
- Article
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1191, doi. 10.1007/s10147-024-02548-6
- By:
- Publication type:
- Article
Impact of timing of urinary drainage on clinical outcomes in patients with obstructive pyelonephritis associated with upper urinary tract stones: a propensity score‑matched analysis.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-04871-z
- By:
- Publication type:
- Article
Prognostic factors for overall survival in clinical node‐positive patients with upper tract urothelial carcinoma.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 4, p. 386, doi. 10.1111/iju.15380
- By:
- Publication type:
- Article